Figure 7From: Systematic review and meta-analysis of Endostar (rh-endostatin) combined with chemotherapy versus chemotherapy alone for treating advanced non-small cell lung cancerMeta-analysis of anemia and nausea/vomiting between Endostar combined with PBDC and PBDC alone. OR, odds ratios; PBDC, conventional platinum-based doublet chemotherapy.Back to article page